Financhill
Back

Edgewise Therapeutics Quote, Financials, Valuation and Earnings

Edgewise Therapeutics Price Quote

$31.59
-1.28 (-3.89%)
(Updated: November 15, 2024 at 2:15 PM ET)

Edgewise Therapeutics Key Stats

Buy
58
Edgewise Therapeutics (EWTX) is a Buy

Day range:
$32.40 - $33.99
52-week range:
$5.93 - $38.12
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
6.37%

Volume:
517.7K
Avg. volume:
898.1K
1-year change:
404.92%
Market cap:
$3.1B
Revenue:
$0
EPS:
$-1.5

How Much Does Edgewise Therapeutics Make?

Data Unavailable

Is Edgewise Therapeutics Growing As A Company?

Data Unavailable

Edgewise Therapeutics Stock Price Performance

What Is Edgewise Therapeutics 52-Week High & Low?

Edgewise Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Edgewise Therapeutics?

Is Edgewise Therapeutics Cash Flow Positive?

  • What Is EWTX Cash Flow From Operations?
    Cash flow from operations (TTM) is -$108.9M
  • What Is Edgewise Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $299.3M
  • What Is Edgewise Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$178.6M

Edgewise Therapeutics Return On Invested Capital

Data Unavailable

Edgewise Therapeutics Earnings Date & Stock Price

Edgewise Therapeutics Competitors

Edgewise Therapeutics Dividend Yield

Edgewise Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 3.27%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 43.17
Upside from Last Price: 31.33%

Major Shareholders

  • How many EWTX shares are owned by institutional investors?
    145.6M EWTX shares are owned by institutional investors
  • How many EWTX shares are owned by insiders?
    183.3K EWTX shares are owned by insiders